Holen Sie sich die Stockscreener-App
0.816
2.04%
-0.017
Handel nachbörslich:
.82
0.004
+0.49%
Schlusskurs vom Vortag:
$0.833
Offen:
$0.84
24-Stunden-Volumen:
202.13K
Relative Volume:
0.45
Marktkapitalisierung:
$54.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-46.12M
KGV:
-0.9442
EPS:
-0.8642
Netto-Cashflow:
$-41.02M
1W Leistung:
-2.86%
1M Leistung:
-7.28%
6M Leistung:
-69.78%
1J Leistung:
-40.87%
1-Tages-Spanne:
$0.7946
$0.84
1-Wochen-Bereich:
$0.7406
$0.86
52-Wochen-Spanne:
$0.7113
$2.815
Inflarx N V Stock (IFRX) Company Profile
Vergleichen Sie IFRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IFRX
Inflarx N V
|
0.816 | 56.43M | 0 | -46.12M | -41.02M | -0.8642 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Inflarx N V Stock (IFRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-29 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-05 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-02-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-10-28 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-03-11 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-11-06 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-10-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-06-17 | Eingeleitet | BTIG Research | Buy |
| 2020-04-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-06-05 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-06-05 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-06-05 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2019-06-05 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-06-05 | Herabstufung | SunTrust | Buy → Hold |
| 2019-01-29 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-12-10 | Eingeleitet | Credit Suisse | Outperform |
| 2018-07-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2018-06-28 | Eingeleitet | Raymond James | Outperform |
| 2018-06-28 | Eingeleitet | SunTrust | Buy |
| 2018-02-08 | Eingeleitet | B. Riley FBR, Inc. | Buy |
Alle ansehen
Inflarx N V Aktie (IFRX) Neueste Nachrichten
Real time social sentiment graph for InflaRx N.V.2025 Big Picture & Verified Entry Point Signals - Newser
Key resistance and support levels for InflaRx N.V. [July 2025 Retail]Long-Term Growth Portfolio Plans - Newser
InflaRx N.V. stock momentum explainedFree Real-Time Market Sentiment Tracking Tool - Newser
InflaRx N.V. stock daily chart insightsSector Rotation Outlook With Historical Summary - Newser
What makes InflaRx N.V. stock price move sharplyProfitable Growth Stock Plan - newsyoung.net
Sector ETF performance correlation with InflaRx N.V.Free Real Time Trade Opportunity Alerts - Newser
Is InflaRx N.V. benefiting from interest rate changesPrime Return Investing Tips - mustnews.co.kr
What MACD signals say about InflaRx N.V.Free Breakout Momentum Picks With Protection - Newser
Predicting InflaRx N.V. trend using moving averagesFree Daily Stock Market Swing Alerts - Newser
Is InflaRx N.V. Stock a Good Fit for Conservative InvestorsEntry Optimization Guide with Volume Analysis - Newser
How high can InflaRx N.V. stock goFree Access to Smart Investment Tips - Newser
Sentiment analysis tools applied to InflaRx N.V.Daily Stock Movement Forecast with Accuracy - Newser
Is it time to cut losses on InflaRx N.V.Free Entry Alert With Low Drawdown Strategy - Newser
Published on: 2025-08-10 03:26:25 - Newser
InflaRx N.V. stock chart pattern explainedFree Breakout Momentum Picks With Protection - Newser
Key resistance and support levels for InflaRx N.V.Downside Risk Evaluation and Stock Analysis - Newser
Is InflaRx N.V. stock reversal real or fakeFree Trend Following Strategy With Stop Loss - Newser
Why InflaRx N.V. stock attracts strong analyst attentionShort-Term Upside Breakout Forecast System - Newser
InflaRx NV reports results for the quarter ended June 30Earnings Summary - TradingView
InflaRx N.V. (IFRX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
InflaRx Reports Significant Losses in H1 2025 Financials - TipRanks
InflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
InflaRx Reveals Timeline for Key Phase 2a Results: Oral C5aR Inhibitor Data Coming in Two Major Skin Diseases - Stock Titan
Applying chart zones and confluence areas to InflaRx N.V.Technical Setup Guide for Daily Watchlist - Newser
Is it time to cut losses on InflaRx N.VFree Fast Exit and Entry Strategy Guide - Newser
What to do if you’re stuck in InflaRx N.V.Trade Safety Matrix for Conservative Traders - Newser
Understanding InflaRx N.V.’s price movementPrice Action Based Buy Zone Forecast - Newser
Tools to assess InflaRx N.V.’s risk profileFree Profit Target Stock Opportunity Monitor - Newser
Finanzdaten der Inflarx N V-Aktie (IFRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):